John Simes
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.2%
- Lipoproteins and Cardiovascular Health
- Coronary Interventions and Diagnostics
Papers in
-
- Acute Myocardial Infarction Research 4
- Antiplatelet Therapy and Cardiovascular Diseases 4
-
- Health Systems, Economic Evaluations, Quality of Life 13
- Pharmaceutical Economics and Policy 4
- Co-authors
- Jonathan EmbersonColin BaigentLisa BlackwellAnthony KeechChristina ReithElizabeth H BarnesR PetoNeeraj Bhala
- Journals
- Circulation (6 papers)European Heart Journal (5 papers)The Lancet (4 papers)Journal of Clinical Oncology (3 papers)PharmacoEconomics (2 papers)
- Partner nations
- AustraliaUnited KingdomCanada
In The Last Decade
John Simes
40 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Endocrinology, Diabetes and Metabolism 2.0k
- Surgery 5.0k
- Cardiology and Cardiovascular Medicine 2.3k
- Internal Medicine 337
- Economics and Econometrics 1.9k
Countries citing papers authored by John Simes
This map shows the geographic impact of John Simes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Simes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Simes more than expected).
Fields of papers citing papers by John Simes
This network shows the impact of papers produced by John Simes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Simes. The network helps show where John Simes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Simes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 5 | |
| 6 | 2018 | 5 | |
| 7 | Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis Hit paper breakdown → | 2017 | 320 |
| 8 | 2017 | 12 | |
| 9 | 2016 | 2 | |
| 10 | 2014 | 186 | |
| 11 | 2011 | 1 | |
| 12 | Abstract 19010: Low HDL-C Carries Residual Risk Even at Target LDL-C Among Patients in the Cholesterol Treatment Trialists' Collaboration Studies | 2010 | 1 |
| 13 | 2010 | 42 | |
| 14 | Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Hit paper breakdown → | 2010 | 4433 |
| 15 | 2008 | 59 | |
| 16 | 2005 | 107 | |
| 17 | 2005 | 13 | |
| 18 | 2004 | 11 | |
| 19 | 2002 | 68 | |
| 20 | Amplification of clinical benefit at six months with the glycoprotein IIb/IIIa inhibitor lamifiban in patients with non ST segment elevation in acute coronary syndromes | 1997 | 4 |
About John Simes
John Simes is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Family Practice, Cancer Research and Surgery, having authored 40 papers that have together received 7.5k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Lipoproteins and Cardiovascular Health (10 papers), Acute Myocardial Infarction Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Pharmaceutical Economics and Policy (4 papers), Coronary Interventions and Diagnostics (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.0k citations), Surgery (5.0k citations), Cardiology and Cardiovascular Medicine (2.3k citations), Internal Medicine (337 citations) and Economics and Econometrics (1.9k citations). John Simes has collaborated with scholars based in Australia, United Kingdom and Canada. Frequent co-authors include Jonathan Emberson, Colin Baigent, Lisa Blackwell, Anthony Keech, Christina Reith, Elizabeth H Barnes, R Peto, Neeraj Bhala, L E Holland and Andrew Tonkin. Their work appears in journals such as Circulation, European Heart Journal, The Lancet, Journal of Clinical Oncology and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.